{"id":1920,"date":"2023-03-16T12:20:57","date_gmt":"2023-03-16T12:20:57","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=1920"},"modified":"2023-03-16T12:20:58","modified_gmt":"2023-03-16T12:20:58","slug":"mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/","title":{"rendered":"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors."},"content":{"rendered":"\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-174-1024x1024.png\" alt=\"\" class=\"wp-image-1921\" width=\"192\" height=\"192\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-174-1024x1024.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-174-300x300.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-174-150x150.png 150w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-174-768x768.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-174.png 1200w\" sizes=\"(max-width: 192px) 100vw, 192px\" \/><\/figure>\n\n\n\n<p>Cambridge, MA\u2014 <a href=\"https:\/\/www.mediartx.com\/\">Mediar Therapeutics<\/a>, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by <a href=\"https:\/\/www.lilly.com\/\">Eli Lilly and Company<\/a>, <a href=\"https:\/\/www.pfizer.com\/\">Pfizer<\/a>, <a href=\"https:\/\/sofinnovapartners.com\/\">Sofinnova Partners<\/a>, <a href=\"https:\/\/www.linkedin.com\/company\/missionbiocapital\/about\/\">Mission BioCapital<\/a>, <a href=\"https:\/\/www.massgeneralbrigham.org\/en\/research-and-innovation\/innovation\/ventures\">Mass General Brigham Ventures<\/a>, and <a href=\"https:\/\/www.bms.com\/\">Bristol Myers Squibb<\/a> with additional investments from <a href=\"https:\/\/www.pureosbio.com\/\">Pureos Bioventures<\/a> and <a href=\"https:\/\/www.gimv.com\/en\">Gimv<\/a>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"472\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-175-1024x472.png\" alt=\"\" class=\"wp-image-1922\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-175-1024x472.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-175-300x138.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-175-768x354.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-175.png 1455w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>The funding will be used to further Mediar\u2019s research into its breakthrough approach to halting fibrosis at the source \u2013 the fibrotic mediators that drive disease progression. Founded by Rahul Ballal based on a deep understanding of the complex science underlying fibrosis onset and progression, Mediar is derisking the path forward for developing novel therapies for this serious condition with reliable biomarkers and familiar modalities.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"491\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-176-1024x491.png\" alt=\"\" class=\"wp-image-1923\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-176-1024x491.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-176-300x144.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-176-768x368.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-176.png 1300w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>\u201cThis is an incredibly exciting time for Mediar as we move closer to our goal of advancing treatments for patients with fibrosis around the world,&#8221; said <a href=\"https:\/\/www.linkedin.com\/in\/ballal\/\">Rahul Ballal<\/a>, CEO of Mediar Therapeutics. &#8220;We are grateful for our investors\u2019 support as we continue our mission to make impactful improvements in patient outcomes.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by Eli Lilly and Company, Pfizer, Sofinnova Partners, Mission BioCapital, Mass General Brigham Ventures, and Bristol Myers Squibb with additional investments from Pureos Bioventures and Gimv. The funding will [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":1925,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors. - Founder Lodge Latest News Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.<\/title>\n<meta name=\"description\" content=\"Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by Eli Lilly and Company, Pfizer, Sofinnova Partners, Mission BioCapital, Mass General Brigham Ventures, and Bristol Myers Squibb with additional investments from Pureos Bioventures and Gimv.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors. - Founder Lodge Latest News Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.\" \/>\n<meta property=\"og:description\" content=\"Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by Eli Lilly and Company, Pfizer, Sofinnova Partners, Mission BioCapital, Mass General Brigham Ventures, and Bristol Myers Squibb with additional investments from Pureos Bioventures and Gimv.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T12:20:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-16T12:20:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/Mediar-Therapeutics_11zon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"581\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ucheezuma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ucheezuma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/\"},\"author\":{\"name\":\"ucheezuma\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\"},\"headline\":\"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.\",\"datePublished\":\"2023-03-16T12:20:57+00:00\",\"dateModified\":\"2023-03-16T12:20:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/\"},\"wordCount\":181,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/\",\"name\":\"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors. - Founder Lodge Latest News Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-03-16T12:20:57+00:00\",\"dateModified\":\"2023-03-16T12:20:58+00:00\",\"description\":\"Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by Eli Lilly and Company, Pfizer, Sofinnova Partners, Mission BioCapital, Mass General Brigham Ventures, and Bristol Myers Squibb with additional investments from Pureos Bioventures and Gimv.\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\",\"name\":\"ucheezuma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"caption\":\"ucheezuma\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors. - Founder Lodge Latest News Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.","description":"Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by Eli Lilly and Company, Pfizer, Sofinnova Partners, Mission BioCapital, Mass General Brigham Ventures, and Bristol Myers Squibb with additional investments from Pureos Bioventures and Gimv.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/","og_locale":"en_US","og_type":"article","og_title":"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors. - Founder Lodge Latest News Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.","og_description":"Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by Eli Lilly and Company, Pfizer, Sofinnova Partners, Mission BioCapital, Mass General Brigham Ventures, and Bristol Myers Squibb with additional investments from Pureos Bioventures and Gimv.","og_url":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-03-16T12:20:57+00:00","article_modified_time":"2023-03-16T12:20:58+00:00","og_image":[{"width":1024,"height":581,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/Mediar-Therapeutics_11zon.png","type":"image\/png"}],"author":"ucheezuma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ucheezuma","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/"},"author":{"name":"ucheezuma","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3"},"headline":"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.","datePublished":"2023-03-16T12:20:57+00:00","dateModified":"2023-03-16T12:20:58+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/"},"wordCount":181,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/","url":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/","name":"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors. - Founder Lodge Latest News Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors.","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-03-16T12:20:57+00:00","dateModified":"2023-03-16T12:20:58+00:00","description":"Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in Cambridge, MA\u2014 Mediar Therapeutics, a biotechnology company pioneering a new approach to fibrosis treatment, announced that it has raised $105M in funding. The round was led by Eli Lilly and Company, Pfizer, Sofinnova Partners, Mission BioCapital, Mass General Brigham Ventures, and Bristol Myers Squibb with additional investments from Pureos Bioventures and Gimv.","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/mediar-therapeutics-raises-105m-in-an-unknown-funding-round-from-leading-healthcare-investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Mediar Therapeutics Raises $105M in An Unknown Funding Round From Leading Healthcare Investors."}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3","name":"ucheezuma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","caption":"ucheezuma"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1920"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=1920"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1920\/revisions"}],"predecessor-version":[{"id":1926,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1920\/revisions\/1926"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/1925"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=1920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=1920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=1920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}